GlaxoSmithKline (GSK) has firmly acquired the number one position in the Egyptian pharmaceutical market ... are driving the bulk of the growth of the company today. GSK maintains a relatively ...

incorporated in the year 1924, is a Large Cap company (having a market cap of Rs 45,050.15 Crore) operating in Pharmaceuticals sector. GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue ...

View upcoming earnings forecasts and in-depth analysis of company forecasts.

Aditya Birla SL ELSS Tax Saver Fund (IDCW) 262.21 9,53,316 1.53 Aditya Birla SL ELSS Tax Saver Fund (G) 262.21 9,53,316 1.53 Aditya Birla SL ELSS Tax Saver Fund ...

On September 30, 2024, State Street Corp made a significant addition to its investment portfolio by acquiring 2,838,484 shares of Crinetics Pharmaceuticals Inc (NASDAQ:CRNX). This transaction ...

Its deal with the US-based AI-driven drug design and development company will see Cloud design novel small-molecule agents to GSK-specified targets. Ed Addison, CEO of Cloud Pharmaceuticals ...

With Gilead Sciences sprinting to a likely approval next year for its long-acting pre-exposure prophylaxis (PrEP) drug for HIV, the California company has a chance to one-up GSK. While the British ...

No Data For Bulk Deal. *Involves transaction of at least 0.5% of the listed shares of a company. What was Glaxosmithkline Pharmaceuticals Ltd share price previously? Glaxosmithkline ...

On September 30, 2024, State Street Corp made a significant addition to its investment portfolio by acquiring 677,024 shares of Ironwood Pharmaceuticals Inc (NASDAQ:IRWD). This transaction ...

View all announcements for GLAXOSMITHKLINE PHARMACEUTICALS LTD. Source: BSE India ...